The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma

ConclusionsThis study suggests that a CPS of  <  1 is not a strong predictor of efficacy but can predict the absence of response to nivolumab in patients with aESCC.

Source: Esophagus - January 3, 2023 Category: Gastroenterology Source Type: research